Three patients had hormone receptor-positive and HER-2 negative breast cancer, one patient presented with co-expression of hormone receptors and HER-2, one patient had triple-negative breast cancer, and another patient presented with hormone-negative breast cancer with unknown HER-2 status. Here, ERBB2 is linked to triple-negative breast carcinoma.